More than an accessory: Implications of type III transforming growth factor-β receptor loss in prostate cancer

Seun Ajiboye, Tristan M. Sissung, Nima Sharifi, William D. Figg

Research output: Contribution to journalShort survey

12 Scopus citations

Abstract

The type III transforming growth factor-β receptor (TGFβR3, betaglycan), a tumour suppressor, is the most frequently lost TGFβ pathway component. This event appears to be very important in the transition of the TGFβ pathway from having tumour-suppressor activity in early prostate tumour development, to having tumour-promoting activity in metastatic disease. Moreover, loss of the TGFβR3 can also affect the cellular response towards testosterone, inhibin/activin, and dysregulate growth-factor pathways that mediate growth and angiogenesis. In this review we discuss how TGFβR3 normally functions as an accessory protein in the TGFβ pathway, how its loss is related to tumour progression, and the treatment implications of TGFβR3 loss in individuals with prostate cancer.

Original languageEnglish (US)
Pages (from-to)913-916
Number of pages4
JournalBJU international
Volume105
Issue number7
DOIs
StatePublished - Apr 1 2010

Keywords

  • Betaglycan
  • Prostate cancer
  • TGFβ III receptor
  • Testosterone

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'More than an accessory: Implications of type III transforming growth factor-β receptor loss in prostate cancer'. Together they form a unique fingerprint.

  • Cite this